Evidence map›Paper›PMID 27144338›Full record

ArticleOncotarget2016

Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.

Sophie Sw Wang, Kenly Wuputra, Chung-Jung Liu, Yin-Chu Lin, Yi-Ting Chen, Chee-Yin Chai, Chen-Lung Steve Lin, Kung-Kai Kuo, Ming-Ho Tsai, Shin-Wei Wang and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Article
  13. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.Journal of experimental & clinical cancer research : CR · 2020
    Review
  14. Review
  15. Review
  16. Potential application of cell reprogramming techniques for cancer research.Cellular and molecular life sciences : CMLS · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Sophie Sw WangDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Kenly WuputraGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chung-Jung LiuDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Yin-Chu LinSchool of Dentistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yi-Ting ChenDepartment of Pathology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Chee-Yin ChaiDepartment of Pathology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Chen-Lung Steve LinGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Kung-Kai KuoDepartment of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Ming-Ho TsaiGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Shin-Wei WangDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Ker-Kong ChenSchool of Dentistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Hiroyuki MiyoshiDepartment of Physiology, Keio University School of Medicine, Shinanomachi, Tokyo 160-8582, Japan.
Yukio NakamuraCell Engineering Division, BioResource Center, RIKEN, Tsukuba, Ibaraki 305-0074, Japan.
Shigeo SaitoSchool of Science and Engineering, Teikyo University, Utsunomia, Tochigi 329-2192, Japan.
Tadashi HanafusaAdvanced Science Research Center, Okayama University, Okayama, Okayama 700-8558, Japan.
Deng-Chyang WuDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Chang-Shen LinGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Kazunari K YokoyamaCenter for Stem Cell Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Kaohsiung Medical University · TWKaohsiung Medical University Chung-Ho Memorial Hospital · TWAdvanced Science Research Center · JPKeio University · JPRIKEN BioResource Research Center · JPTeikyo University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study the mechanisms of gastric tumorigenesis, we have established CSN cell line from human normal gastric mucosa, and CS12, a tumorigenic and invasive gastric cancer cell line from CSN passages. Many stem cell markers were expressed in both CSN and CS12 cells, but LGR5 and NANOG were expressed only in CS12 cells. Increased expression of homeobox A13 (HoxA13) and its downstream cascades was significant for the tumorigenic activity of CS12 cells, and was associated with recruitment of E2F-1 to HoxA13 promoter accompanied with increased trimethylation of histone H3 lysine 4 (H3K4me3) at the hypomethylated E2F motifs. Knockdown of HoxA13 caused the downregulation of long non-coding RNA HOTTIP and insulin growth factor-binding protein 3 (IGFBP-3) genes, indicating that both were targets of HoxA13. Concurrent regulation of HoxA13-HOTTIP was mediated by the mixed lineage leukemia-WD repeat domain 5 complex, which caused the trimethylation of H3K4 and then stimulated cell proliferation. HoxA13 transactivated the IGFBP-3 promoter through the HOX-binding site. Activation of IGFBP-3 stimulated the oncogenic potential and invasion activity. Increased expression of HoxA13 (63.2%) and IGFBP-3 (28.6%) was detected in human gastric cancer tissues and was found in the gastric cancer data of The Cancer Genome Atlas. Taken together, the HoxA13-HOTTIP-IGFBP-3 cascade is critical for the carcinogenic characteristics of CS12 cells.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCarcinogenesisCell LineCell Line, TumorDNA MethylationHomeodomain ProteinsHumansInsulin-Like Growth Factor Binding Protein 3Mice, SCIDOncogenesRNA InterferenceRNA, Long NoncodingStomach NeoplasmsTransplantation, Heterologoushomeobox protein HOXA13Homeodomain ProteinsInsulin-Like Growth Factor Binding Protein 3long noncoding RNA HOTTIP, humanRNA, Long Noncodinggastric cancer cellsHOTTIPHoxA13IGFBP-3p53-E2F signaling

Identifiers

PMID27144338
PMCPMC5094982
OpenAlexW2343369852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.